Jun Bao is responsible for Business Development. He obtained his Ph.D. from the University of Kansas, his Postdocotoral training at Johns Hopkins and MBA from the University of Chicago. Dr. Bao has more than 20 years of comprehensive experience in the production and research, extensive experience in drug research and development, technology transfer, licensing and business development, venture investment, entrepreneurship and corporate finance. He has previously served as President & CEO at IMPACT Therapeutics. He also served as SVP & CBO at Shenogen Pharma, Director of Worldwide BD & Head of China BD at GSK，Director of Corporate Development and Financial Planning at Onyx. Moreover, in Seattle, he worked at ICOS Corporation and Cell Therapeutics as a business development executive with progressive responsibilities.